Market Forecast By Material Types (Living Cells, Hydrogels, Extracellular Matrices, and Others), By Technologies (Micro Extrusion Bioprinting, Magnetic Levitation, Inkjet-Based, Syringe-Based, Laser-Based, and Others), By Components (3D Bioprinters, Biomaterials, and Scaffolds), By Applications ((Research Application (3D Cell Culture, Regenerative Medicine, Drug Testing and Others), Clinical Application (Dental, Orthopedic, Skin Substitutes, and Grafts and Vascular Tissues and Organs)), By End Users (Pharmaceutical & Biotechnology Companies, Research Organizations & Academic Institutes, and Others), By Regions (North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa), By Key Countries and Competitive Landscape
Product Code: ETC000717 | Publication Date: Jan 1970 | Updated Date: Dec 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 | |
The global 3D Bioprinting Market report thoroughly covers the market by material types, technologies, components, applications, end users, and regions. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Global 3D bioprinting market is predicted to increase significantly between 2024 and 2030. This is due to increasing demand for customized treatment, advances in tissue engineering and regenerative medicine, and increased investment in R&D activities.
According to 6Wresearch, Global 3D Bioprinting Market size is expected to grow during 2025-2031. The potential for Global 3D Bioprinting Market to revolutionize healthcare is a major driver of the market's growth. 3D bioprinting, with its ability to manufacture complex, functional tissues and organs, has the potential to drastically improve patient outcomes through individualized treatments. This technology has the potential to minimize the need for animal testing, as well as making medication development faster and less costly.
However, significant problems must be overcome before the industry can attain its full potential. One significant problem is a lack of standardization in 3D bioprinting procedures and materials. This can produce uneven results and impede the general use of this technology. Furthermore, regulatory concerns about safety and efficacy provide a barrier to market growth.
Organovo Holdings Inc., Cellink AB, EnvisionTEC GmbH, and Materialise NV are among the worldwide 3D bioprinting market's leading players. These companies are always spending in R&D to improve their products and stay ahead of the competition.
Governments throughout the world are also seeing the promise of 3D bioprinting and launching programs to help it flourish. For example, the US government has invested millions of dollars in 3D bioprinting research through a variety of entities, including the National Institutes of Health (NIH) and the Defense Advanced Research Projects Agency. Similarly, other countries such as China, Japan, South Korea, and Germany have made efforts to promote this technology through funding and collaboration.
The 3D bioprinting market is likely to increase significantly in the coming years as tissue engineering and regenerative medicine advances. The rising frequency of chronic diseases, an aging population, and increased demand for organ transplants are all predicted to fuel market expansion. Furthermore, cooperation between academic institutes and industry leaders are likely to result in the development of new and novel 3D bioprinting technologies.
Overall, the global 3D bioprinting industry is experiencing rapid expansion and is likely to make substantial advances in the next years. With the potential to improve healthcare, it has piqued the interest of a variety of stakeholders, including governments, research institutes, and industry leaders. As additional advances are achieved in this discipline, we can anticipate an evolution in customized treatment and better patient results. 3D bioprinting's potential for tissue engineering, regenerative medicine, and drug research makes it an intriguing frontier with limitless opportunities for future growth and innovation.
According to Dhaval, Research Manager, 6Wresearch, in the worldwide 3D bioprinting industry, demand for living cells is predicted to expand significantly. This can be ascribed to the growing utilization of living cells to build complex tissues and organs, as well as their potential for tailored therapy. Furthermore, advances in stem cell research and regenerative medicine are projected to promote the expansion of this market.
Micro extrusion bioprinting dominates the global 3D bioprinting market. This is because to its capacity to generate high-resolution structures with multiple cell types and materials, making it suited for a wide range of applications in tissue engineering and drug discovery.
The 3D bioprinters segment now dominates the global market and is likely to grow further in the future years. Key manufacturers are increasing their efforts in creating sophisticated bioprinting machines with higher precision and features, which is driving the growth of this market.
The clinical application segment is predicted to increase significantly in the global 3D bioprinting market. This can be ascribed to the growing need for individualized care, as well as the possibility of 3D bioprinting to create complex tissues and organs for transplant.
The pharmaceutical and biotechnology companies segment dominates the worldwide 3D bioprinting market. This can be linked to the growing usage of 3D bioprinting for medication development, as well as collaborations between these corporations and research institutions to produce tailored therapies.
Asia-Pacific is predicted to see a considerable increase in demand for 3D bioprinting due to its expanding healthcare industry, increased investment in R&D, and rising desire for personalized treatment.
The Global 3D Bioprinting Market report provides a detailed analysis of the following market segments:
1 Executive Summary |
2 Introduction |
2.1 Report Description |
2.2 Key Highlights of The Report |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global 3D Bioprinting Market Overview |
3.1 Global 3D Bioprinting Market Revenues, 2021-2031F |
3.2 Global 3D Bioprinting Market Revenue Share, By Material Type, 2021-2031F |
3.3 Global 3D Bioprinting Market Revenue Share, By Technology, 2021-2031F |
3.4 Global 3D Bioprinting Market Revenue Share, By Component, 2021-2031F |
3.5 Global 3D Bioprinting Market Revenue Share, By Application, 2021-2031F |
3.6 Global 3D Bioprinting Market Revenue Share, By End User, 2021-2031F |
3.7 Global 3D Bioprinting Market Revenue Share, By Regions, 2021-2031F |
3.8 Global 3D Bioprinting Market Industry Life Cycle |
3.9 Global 3D Bioprinting Market- Porter's Five Forces, 2021 |
4 Global 3D Bioprinting Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global 3D Bioprinting Market Trends |
6 Global 3D Bioprinting Market Overview, By Material Type |
6.1 Global 3D Bioprinting Market Revenues, By Living Cells, 2021-2031F |
6.2 Global 3D Bioprinting Market Revenues, By Hydrogels, 2021-2031F |
6.3 Global 3D Bioprinting Market Revenues, By Extracellular Matrices, 2021-2031F |
6.4 Global 3D Bioprinting Market Revenues, By Others, 2021-2031F |
7 Global 3D Bioprinting Market Overview, By Technology |
7.1 Global 3D Bioprinting Market Revenues, By Micro Extrusion Bioprinting, 2021-2031F |
7.2 Global 3D Bioprinting Market Revenues, By Magnetic Levitation, 2021-2031F |
7.3 Global 3D Bioprinting Market Revenues, By Inkjet, Based, 2021-2031F |
7.4 Global 3D Bioprinting Market Revenues, By Syringe, Based, 2021-2031F |
7.5 Global 3D Bioprinting Market Revenues, By Laser-Based, 2021-2031F |
7.6 Global 3D Bioprinting Market Revenues, By Others, 2021-2031F |
8 Global 3D Bioprinting Market Overview, By Component |
8.1 Global 3D Bioprinting Market Revenues, By 3D Bioprinters, 2021-2031F |
8.2 Global 3D Bioprinting Market Revenues, By Biomaterials, 2021-2031F |
8.3 Global 3D Bioprinting Market Revenues, By Scaffolds, 2021-2031F |
9 Global 3D Bioprinting Market Overview, By Application |
9.1 Global 3D Bioprinting Market Revenues, By Research Application, 2021-2031F |
9.1.1 Global 3D Bioprinting Market Revenues, By 3D Cell Culture, 2021-2031F |
9.1.2 Global 3D Bioprinting Market Revenues, By Regenerative Medicine, 2021-2031F |
9.1.3 Global 3D Bioprinting Market Revenues, By Drug Testing, 2021-2031F |
9.1.4 Global 3D Bioprinting Market Revenues, By Others, 2021-2031F |
9.2 Global 3D Bioprinting Market Revenues, By Clinical Application, 2021-2031F |
9.2.1 Global 3D Bioprinting Market Revenues, By Dental, 2021-2031F |
9.2.2 Global 3D Bioprinting Market Revenues, By Orthopedic, 2021-2031F |
9.2.3 Global 3D Bioprinting Market Revenues, By Skin Substitutes and Grafts, 2021-2031F |
9.2.4 Global 3D Bioprinting Market Revenues, By Vascular Tissues and Organs, 2021-2031F |
10 Global 3D Bioprinting Market Overview, By End User |
10.1 Global 3D Bioprinting Market Revenues, By Pharmaceutical & Biotechnology Companies, 2021-2031F |
10.2 Global 3D Bioprinting Market Revenues, By Research Organizations & Academic Institutes, 2021-2031F |
10.3 Global 3D Bioprinting Market Revenues, By Others, 2021-2031F |
11 North America 3D Bioprinting Market Overview |
11.1 North America 3D Bioprinting Market Revenues, 2021-2031F |
11.2 North America 3D Bioprinting Market Revenues, By Material Type, 2021-2031F |
11.3 North America 3D Bioprinting Market Revenues, By Technology, 2021-2031F |
11.4 North America 3D Bioprinting Market Revenues, By Component, 2021-2031F |
11.5 North America 3D Bioprinting Market Revenues, By Application, 2021-2031F |
11.6 North America 3D Bioprinting Market Revenues, By End User, 2021-2031F |
11.7 North America 3D Bioprinting Market Revenues, By Countries, 2021-2031F |
12 Latin America 3D Bioprinting Market Overview |
12.1 Latin America 3D Bioprinting Market Revenues, 2021-2031F |
12.2 Latin America 3D Bioprinting Market Revenues, By Material Type, 2021-2031F |
12.3 Latin America 3D Bioprinting Market Revenues, By Technology, 2021-2031F |
12.4 Latin America 3D Bioprinting Market Revenues, By Component, 2021-2031F |
12.5 Latin America 3D Bioprinting Market Revenues, By Application, 2021-2031F |
12.6 Latin America 3D Bioprinting Market Revenues, By End User, 2021-2031F |
12.7 Latin America 3D Bioprinting Market Revenues, By Countries, 2021-2031F |
13 Europe 3D Bioprinting Market Overview |
13.1 Europe 3D Bioprinting Market Revenues, 2021-2031F |
13.2 Europe 3D Bioprinting Market Revenues, By Material Type, 2021-2031F |
13.3 Europe 3D Bioprinting Market Revenues, By Technology, 2021-2031F |
13.4 Europe 3D Bioprinting Market Revenues, By Component, 2021-2031F |
13.5 Europe 3D Bioprinting Market Revenues, By Application, 2021-2031F |
13.6 Europe 3D Bioprinting Market Revenues, By End User, 2021-2031F |
13.7 Europe 3D Bioprinting Market Revenues, By Countries, 2021-2031F |
14 Asia Pacific 3D Bioprinting Market Overview |
14.1 Asia Pacific 3D Bioprinting Market Revenues, 2021-2031F |
14.2 Asia Pacific 3D Bioprinting Market Revenues, By Material Type, 2021-2031F |
14.3 Asia Pacific 3D Bioprinting Market Revenues, By Technology, 2021-2031F |
14.4 Asia Pacific 3D Bioprinting Market Revenues, By Component, 2021-2031F |
14.5 Asia Pacific 3D Bioprinting Market Revenues, By Application, 2021-2031F |
14.6 Asia Pacific 3D Bioprinting Market Revenues, By End User, 2021-2031F |
14.7 Asia Pacific 3D Bioprinting Market Revenues, By Countries, 2021-2031F |
15 The Middle East and Africa 3D Bioprinting Market Overview |
15.1 the Middle East and Africa 3D Bioprinting Market Revenues, 2021-2031F |
15.2 the Middle East and Africa 3D Bioprinting Market Revenues, By Material Type, 2021-2031F |
15.3 the Middle East and Africa 3D Bioprinting Market Revenues, By Technology, 2021-2031F |
15.4 the Middle East and Africa 3D Bioprinting Market Revenues, By Component, 2021-2031F |
15.5 the Middle East and Africa 3D Bioprinting Market Revenues, By Application, 2021-2031F |
15.6 the Middle East and Africa 3D Bioprinting Market Revenues, By End User, 2021-2031F |
15.7 the Middle East and Africa 3D Bioprinting Market Revenues, By Countries, 2021-2031F |
16 Global 3D Bioprinting Market Opportunity Assessment |
16.1 Global 3D Bioprinting Market Opportunity Assessment, By Material Type, 2030F |
16.2 Global 3D Bioprinting Market Opportunity Assessment, By Technology, 2030F |
16.3 Global 3D Bioprinting Market Opportunity Assessment, By Component, 2030F |
16.4 Global 3D Bioprinting Market Opportunity Assessment, By Application, 2030F |
16.5 Global 3D Bioprinting Market Opportunity Assessment, By End User, 2030F |
17 Global 3D Bioprinting Market Competitive Landscape |
17.1 Global 3D Bioprinting Market Revenue Share, By Companies, 2021 |
17.1.1 North America 3D Bioprinting Market Revenue Share, By Companies, 2021 |
17.1.2 Latin America 3D Bioprinting Market Revenue Share, By Companies, 2021 |
17.1.3 Europe 3D Bioprinting Market Revenue Share, By Companies, 2021 |
17.1.4 Asia-Pacific 3D Bioprinting Market Revenue Share, By Companies, 2021 |
17.1.5 the Middle East and Africa 3D Bioprinting Market Revenue Share, By Companies, 2021 |
17.2 Global 3D Bioprinting Market Competitive Benchmarking, By Operating Parameters |
18 Company Profiles |
19 Strategic Recommendations |
20 Disclaimer |
Market Forecast By Material Types (Living Cells, Hydrogels, Extracellular Matrices, and Others), By Technologies (Micro Extrusion Bioprinting, Magnetic Levitation, Inkjet-Based, Syringe-Based, Laser-Based, and Others), By Components (3D Bioprinters, Biomaterials, and Scaffolds), By Applications ((Research Application (3D Cell Culture, Regenerative Medicine, Drug Testing and Others), Clinical Application (Dental, Orthopedic, Skin Substitutes, and Grafts and Vascular Tissues and Organs)), By End Users (Pharmaceutical & Biotechnology Companies, Research Organizations & Academic Institutes, and Others), By Regions (North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa), By Key Countries and Competitive Landscape
Product Code: ETC000717 | Publication Date: Jun 2022 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 |
Global 3D Bioprinting Market report thoroughly covers the market by material type, technology, component, application, end-users, and regions. The global 3D bioprinting market outlook report provides an unbiased and detailed analysis of the ongoing global 3D bioprinting market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Global 3D Bioprinting market is anticipated to project momentum during the forthcoming years with the rise in the elderly population across various regions of the globe. Further, growing technological advancements in medicine, increasing investment by the companies, and a large gap in demand and supply of organ transplants are driving the global 3D Bioprinting market. The usage of 3D printing in cosmetic surgeries and inventions in 3D bioprinting is expected to further supplement the 3D bioprinting market growth during the forecast period. 3D Bioprinting is attributed to used to raise the incidence of chronic diseases such as kidney failure and heart and limit the number of organ donors.
According to 6Wresearch, the global 3D bioprinting market is anticipated to register growth during 2019-2025. Factors such as technological advancement for manufacturing customized products and rising R&D investment are accelerating the 3D bioprinting market share. IT companies investing in the healthcare industry and boosting the market growth. Institute for Technology Inspired Regenerative Medicine based on the Bioprinting, the advancements in 3D printing, and regenerative medicine. At the global level, 3D bioprinting is going to demand in the market during the forecast period. 3D bioprinting of the bio-mimetic microstructure is used at the global level for cancer cell migration studies. Further, an increase in the leveraging of the technology for prototypes, tools, and fixtures along with finished products is anticipated to drive revenues for the global 3D printing market in the coming years. Also, Aerospace, automotive, and defense are the mature industries that are increasing the deployment of the 3D printing technology and would witness an increase in the adoption of the technology owing to the technological advancements across these sectors and would, further, proliferate the growth of the Global 3D printing market in the near future.
In the overall global 3D bioprinting market share, North America has captured a major revenue pie in 2018 and is expected to lead throughout the forecast period. North America would lead on account of advancements in the medical field, a growing number of patients with organ failures along with low availability of organ donors resulting in the acceptance of 3D bioprinted products. The rise in the practice of 3D bioprinting in cosmetic surgery is anticipated to further lead the market growth over the coming years.
In terms of technology, the market can be categorized into micro extrusion bioprinting, magnetic levitation, inkjet-based, syringe-based, laser-based, and others, where the syringe-based segment has generated key market revenues. Over the next six years, magnetic levitation is anticipated to record relatively higher growth than others.
• Global 3D Bioprinting Market Overview
• Global 3D Bioprinting Market Outlook
• Global 3D Bioprinting Market Forecast
• Historical Data of Global 3D Bioprinting Market Revenues for the Period 2015-2018
• Global 3D Bioprinting Market Size and Global 3D Bioprinting Market Forecast of Revenues, Until 2025
• Historical Data of Global 3D Bioprinting Market Revenues, By Material Type, for the Period 2015-2018
• Market Size & Forecast of Global 3D Bioprinting Market Revenues, By Material Type, Until 2025
• Historical Data of Global 3D Bioprinting Market Revenues, By Technology, for the Period 2015-2018
• Market Size & Forecast of Global 3D Bioprinting Market Revenues, By Technology, Until 2025
• Historical Data of Global 3D Bioprinting Market Revenues, By Component, for the Period 2015-2018
• Market Size & Forecast of Global 3D Bioprinting Market Revenues, By Component, Until 2025
• Historical Data of Global 3D Bioprinting Market Revenues, By Applications, for the Period 2015-2018
• Market Size & Forecast of Global 3D Bioprinting Market Revenues, By Applications, Until 2025
• Historical Data of Global 3D Bioprinting Market Revenues, By End User, for the Period 2015-2018
• Market Size & Forecast of Global 3D Bioprinting Market Revenues, By End User, Until 2025
• Historical Data of North America 3D Bioprinting Market Revenues, for the Period 2015-2018
• Market Size & Forecast of North America 3D Bioprinting Market Revenues, Until 2025
• Historical Data of Latin America 3D Bioprinting Market Revenues, for the Period 2015-2018
• Market Size & Forecast of Latin America 3D Bioprinting Market Revenues, Until 2025
• Historical Data of Europe 3D Bioprinting Market Revenues, for the Period 2015-2018
• Market Size & Forecast of Europe 3D Bioprinting Market Revenues, Until 2025
• Historical Data of Asia Pacific 3D Bioprinting Market Revenues, for the Period 2015-2018
• Market Size & Forecast of Asia Pacific 3D Bioprinting Market Revenues, Until 2025
• Historical Data of the Middle East & Africa 3D Bioprinting Market Revenues, for the Period 2015-2018
• Market Size & Forecast of the Middle East & Africa 3D Bioprinting Market Revenues, Until 2025
• Market Drivers and Restraints
• Global 3D Bioprinting Market Price Trends
• Global 3D Bioprinting Market Trends and Industry Life Cycle
• Porter’s Five Force Analysis
• Market Opportunity Assessment
• Global 3D Bioprinting Market Share, By Material Type, By Players
• Global 3D Bioprinting Market Overview on Competitive Benchmarking
• Company Profiles
• Key Strategic Recommendations
The Global 3D Bioprinting Market report provides a detailed analysis of the following market segments:
o Research Application
? 3D Cell Culture
? Regenerative Medicine
? Drug Testing
? Others
o Clinical Application
? Dental
? Orthopedic
? Skin Substitutes and Grafts
? Vascular Tissues and Organs